e-learning
resources
Paris 2018
Sunday, 16.09.2018
Cardiovascular morbidities in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
A. Hemat (Duesseldorf, Germany), P. Müller (Duesseldorf, Germany), C. Jung (Duesseldorf, Germany), S. Krüger (Duesseldorf, Germany), S. Keymel (Duesseldorf, Germany)
Source:
International Congress 2018 – Cardiovascular morbidities in COPD
Session:
Cardiovascular morbidities in COPD
Session type:
Thematic Poster
Number:
745
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hemat (Duesseldorf, Germany), P. Müller (Duesseldorf, Germany), C. Jung (Duesseldorf, Germany), S. Krüger (Duesseldorf, Germany), S. Keymel (Duesseldorf, Germany). Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm. 745
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
Source: Eur Respir J 2007; 30: Suppl. 51, 707s
Year: 2007
The frequency of the cardiac arrhythmias of the patients who suffer from the chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Possible mechanisms of ventricular arrhythmias in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019
NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Peculiarities of cardiac rhythm in stable chronic obstructive pulmonary disease
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Undiagnosed and untreated rhythm disturbances and arterial hypertension in development of chronic obstructive lung disease exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 623s
Year: 2006
The relationship between chronic obstructive pulmonary disease exacerbations and right ventricular function
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Heart arrhythmias in patients with chronic obstructive bronchitis and ischemic heart disease
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012
Mechanisms of Cardiac arrhythmias in patients with chronic obstructive disease (COPD)
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Complex right ventricular response to pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003
The respiratory circadian rhythm disturbances in the patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept